News search

    E.g., 02/09/2024
    E.g., 02/09/2024
    Atrial electroanatomic map of a pig with persistent AFib. The regions colored magenta, purple, and dark blue have high mean FM values. These regions maintain the AFib, and their ablation with a catheter stops the arrhythmia. The squares represent the sites of rotational activity, which are sensitive but not specific to the regions that maintain the fibrillation.
    Research
    12 Sep 2019
    Circulation Research: A new method to improve treatment of atrial fibrillation

    The new study was conducted by investigators at the CNIC, the Hospital Clínico San Carlos in Madrid, and the CiberCV research network and is featured on the cover of the latest edition of the journal Circulation Research

    From left to right: Marta Román, Fernando Domínguez, Laura Padrón-Barthe, Pablo Garcia-Pavia, Giovanna Giovinazzo, Enrique Lara-Pezzi, Demetrio J. Santiago, Javier Larrasa-Alonso
    Research
    5 Sep 2019
    Circulation: Possible treatment breakthrough for the rare disease arrhythmogenic right ventricular cardiomyopathy type 5

    Scientists at the Centro Nacional de Investigaciones Cardiovasculares (CNIC) and Puerta de Hierro hospital in Majadahonda have found a possible treatment for this disease
    About the CNIC
    9 Jul 2019
    JACC: The CNIC is the coordinator of an international consensus document on the use of magnetic resonance imaging after a heart attack
    SRSF3 expression in adult cardiomyocytes. Pink staining shows SRSF3 expression in cell nuclei, which are stained blue. Green staining shows the presence of troponin, a sarcomere protein expressed in cardiomyocytes.
    Research
    4 Jul 2019
    Circulation Research: CNIC scientists identify an essential protein for correct heart contraction and survival

    A new study published in Circulation Research shows that loss of cardiac expression of SRSF3 leads to a critical reduction in the expression of genes related to contraction
    Rui Benedito, Macarena Fernández Chacón, Verónica Casquero García, Federica Lunella y Wen Luo.
    Research
    22 May 2019
    Nature Communications: A new genetic tool to modify and understand gene function

    CNIC scientists have developed a new genetic tool that significantly facilitates the study of gene function in physiological conditions and disease.
    Luis Leiva-Vega, Juan Antonio Bernal, Marta Roche-Molina, Ayelén M. Santamans, Valle Montalvo-Romeral, Aránzazu Pintor-Chocano, Rafael Romero-Becerra, Ainoa Caballero, Alfonso Mora, Guadalupe Sabio, Antonia Tomás-Loba, Marta León, Elena Rodríguez, Juan Antonio López, Jesús Vázquez.
    Research
    11 Apr 2019
    Nature: The protein p38gamma identified as a new therapeutic target in liver cancer

    CNIC scientists have shown for the first time that a protein related to cell stress also regulates cell division
    Pilar Gonzalo, Rosa Nevado, Ricardo Villa-Bellosta, Magda R. Hamczyk, María J. Andrés-Manzano, and Vicente Andrés.
    Research
    12 Mar 2019
    EMBO Molecular Medicine: CNIC scientists discover a new therapeutic target for blocking early atherosclerosis in progeria

    This new results, published in EMBO Molecular Medicine, identify a possible therapeutic target for this genetic disease
    About the CNIC
    18 Jan 2019
    The Pro CNIC Foundation extends its commitment with the CNIC until 2028
    • ·         The Pro CNIC Foundation prolongs its commitment until 2028, with the excellent cardiovascular research carried out at the CNIC under the management of Dr. Valentín Fuster
    • ·         The innovative public-private financing formula has allowed the CNIC to reach a very high level of excellence, making it worthy of the Severo Ochoa accreditation and other international recognitions 
    • The Pro CNIC joins together 12 of the most important companies in Spain: Acciona, Santander Bank, BBVA, Endesa, Mapfre Foundation, Mutua Madrileña Foundation, Ramón Areces Foundation, Repsol Foundation, Inditex, "la Caixa", Prisa and Telefónica.
    Research
    16 Jan 2019
    JACC: The duration and quality of sleep is of vital importance in cardiovascular health

    Poor quality sleep increases the risk of atherosclerosis according to the PESA CNIC- Santander Study published in the Journal of the American College of Cardiology (JACC)
    About the CNIC
    30 Nov 2018
    A Project by Borja Ibáñez from the CNIC and the FJD funded by the European Union with an ‘ERC Consolidator’